These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 17253562)

  • 1. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome.
    Costello M; Shrestha B; Eden J; Sjoblom P; Johnson N
    Cochrane Database Syst Rev; 2007 Jan; (1):CD005552. PubMed ID: 17253562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin versus oral contraceptive pill in polycystic ovary syndrome: a Cochrane review.
    Costello MF; Shrestha B; Eden J; Johnson NP; Sjoblom P
    Hum Reprod; 2007 May; 22(5):1200-9. PubMed ID: 17261574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Xiong T; Fraison E; Kolibianaki E; Costello MF; Venetis C; Kostova EB
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008565. PubMed ID: 37462232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Raval AD; Hunter T; Stuckey B; Hart RJ
    Cochrane Database Syst Rev; 2011 Oct; (10):CD008565. PubMed ID: 21975784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Morley LC; Tang T; Yasmin E; Norman RJ; Balen AH
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003053. PubMed ID: 29183107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2010 Jan; (1):CD003053. PubMed ID: 20091537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003053. PubMed ID: 19821299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome.
    Lord JM; Flight IH; Norman RJ
    Cochrane Database Syst Rev; 2003; (3):CD003053. PubMed ID: 12917943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2012 May; (5):CD003053. PubMed ID: 22592687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ovarian surgery for symptom relief in women with polycystic ovary syndrome.
    Lepine S; Jo J; Metwally M; Cheong YC
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD009526. PubMed ID: 29125183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WITHDRAWN: Insulin-sensitising drugs for polycystic ovary syndrome.
    Tang T; Lord JM; Norman RJ; Yasmin E; Balen AH
    Cochrane Database Syst Rev; 2009 Jul; (3):CD003053. PubMed ID: 19588338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin or Oral Contraceptives for Adolescents With Polycystic Ovarian Syndrome: A Meta-analysis.
    Al Khalifah RA; Florez ID; Dennis B; Thabane L; Bassilious E
    Pediatrics; 2016 May; 137(5):. PubMed ID: 27244814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for hirsutism (excluding laser and photoepilation therapy alone).
    van Zuuren EJ; Fedorowicz Z; Carter B; Pandis N
    Cochrane Database Syst Rev; 2015 Apr; 2015(4):CD010334. PubMed ID: 25918921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacy of oral insulin sensitizers metformin, thiazolidinediones, inositol, and berberine in improving endocrine and metabolic profiles in women with PCOS: a network meta-analysis.
    Zhao H; Xing C; Zhang J; He B
    Reprod Health; 2021 Aug; 18(1):171. PubMed ID: 34407851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of the combined oral contraceptive pill and/or metformin in the management of polycystic ovary syndrome: A systematic review with meta-analyses.
    Teede H; Tassone EC; Piltonen T; Malhotra J; Mol BW; Peña A; Witchel SF; Joham A; McAllister V; Romualdi D; Thondan M; Costello M; Misso ML
    Clin Endocrinol (Oxf); 2019 Oct; 91(4):479-489. PubMed ID: 31087796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome.
    Tso LO; Costello MF; Albuquerque LE; Andriolo RB; Freitas V
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006105. PubMed ID: 19370625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
    Teede HJ; Meyer C; Hutchison SK; Zoungas S; McGrath BP; Moran LJ
    Fertil Steril; 2010 Jan; 93(1):184-91. PubMed ID: 19019358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2003; (4):CD000194. PubMed ID: 14583916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular action of insulin-sensitizing agents].
    Kacalska O; Krzyczkowska-Sendrakowska M; Milewicz T; Zabińska-Popiela M; Bereza T; Krzysiek-Maczka G; Krzysiek J
    Endokrynol Pol; 2005; 56(3):308-13. PubMed ID: 16350724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.